Company Overview and News

 
India's GAIL Says LNG Supply From Gazprom Will Start From May

2018-04-12 rigzone
NEW DELHI, April 12 (Reuters) - India's state-owned gas supplier and developer GAIL Ltd plans to buy 0.5 million tonnes or eight cargoes of liquefied natural gas (LNG) from Russia's Gazprom in 2018/19, its chairman and managing director B.C. Tripathi said.
Upvote Downvote

 
Closing Bell: Nifty manages to hold 10,400, Sensex ends higher for 5th day

2018-04-11 moneycontrol
3:30 pm Market Closing: Benchmark indices closed higher for fifth consecutive session on Wednesday. The 30-share BSE Sensex was up 60.19 points at 33,940.44 and the 50-share NSE Nifty rose 14.90 points to 10,417.20.
Upvote Downvote

 
Deals of the day-Mergers and acquisitions

2018-04-11 reuters
April 11 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday:
Upvote Downvote

 
Market Live: Nifty hovers around 10,400; PSU Bank dips 2%, RIL extends gains

2018-04-11 moneycontrol
2:50 pm Europe Lower: Equities in Europe moved lower as investors began to focus on earnings at the start of a new reporting season.
Upvote Downvote

 
Petronet LNG to partner with ONGC Videsh to pick stake in Qatar project

2018-04-11 economictimes.indiatimes
Copyright © 2018 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service
Upvote Downvote

 
Petronet LNG Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Bharat Petroleum may hive off gas business into separate wholly owned subsidiary

2018-04-08 livemint
Mumbai:State-run Bharat Petroleum Corporation Ltd (BPCL) is planning to hive off its gas business into a separate wholly-owned subsidiary, two people aware of the development said.
Upvote Downvote

 
Petronet LNG Limited - Updates

2018-04-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Broker’s Call: Petronet LNG (Buy)

2018-03-12 thehindubusinessline
We believe Petronet’s earnings will continue to rise over the next 2-3 years, driven by higher volumes from Dahej LNG regasification terminal and a higher operating rate of the currently stranded Kochi terminal. Construction of the pipeline to evacuate gas from Kochi is progressing well. Petronet is eyeing to invest in the overseas LNG market which will help it in geographical diversification and further expansion.
Upvote Downvote

 
Cabinet approves feasibility of India, Japan aided LNG terminal & storage

2018-02-28 lankabusinessonline
Feb 28, 2018 (LBO) – Sri Lanka’s cabinet on Tuesday approved a proposal to conduct a feasibility study for the proposed Liquefied Natural Gas (LNG) Terminal and the Floating Storage Regasification Unit (FSRU).
Upvote Downvote

 
ONGC Videsh drops plan to build LNG export facility in Iran

2018-02-25 livemint
New Delhi: ONGC Videsh Ltd has shelved plans to build a $5 billion LNG export facility in Iran and has instead opted to only invest in developing a giant gas field in the Persian Gulf, for which a revised cost is being worked out, an official said.
Upvote Downvote

 
Petronet eyeing ‘eco-structure’ to boost LNG adoption: CEO Prabhat Singh

2018-02-22 livemint
Mumbai: Petronet LNG Ltd, India’s largest importer of liquid gas, plans to set up a liquefied natural gas eco-structure, Prabhat Singh, chief executive and managing director of the company said.
Upvote Downvote

 
Closing Bell: Sensex, Nifty end off day#39;s low; RIL, Infosys, Axis Bank rebound

2018-02-19 moneycontrol
3:30 pm Market Closing: Benchmark indices closed below their 100-day moving average, with the Sensex losing 236.10 points to 33,774.66 and the Nifty down 73.90 points at 10,378.40 after recovered from day's low.
Upvote Downvote

 
Essar sells CBM gas to GAIL using Reliance formula

2018-02-15 moneycontrol
Essar Oil has sold its entire production of coal-seam gas or CBM from a West Bengal block to state-owned GAIL India Ltd using the same formula that Reliance Industries used for pricing of its CBM.
Upvote Downvote

 
ONGC Videsh offers to invest $6.2 bn in Iran's giant Farzad-B gas field

2018-02-14 business-standard
With negotiations stuck over pricing of natural gas, ONGC Videsh Ltd has offered to invest USD 6.2 billion in development of Iran's giant Farzad-B gas field in the Persian Gulf while leaving the marketing of gas to Tehran. OVL had last year made its 'best' offer to spend USD 11 billion in developing the Farzad-B field as well as in building the infrastructure to export the gas but Iran has deterred awarding the rights of the field to the Indian firm owing to differences over pricing of the fuel.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...